The published record points to one dominant reality: most peptides are injected, not swallowed, because the digestive tract dismantles amino-acid chains before they ever reach the bloodstream. Dose is product-specific, expressed in milligrams, micrograms, or international units, and tied to the molecule, the purpose, and often body weight. For a reader weighing whether a peptide is something to obtain through a clinician or a gray-market vendor, the honest bottom line is that accurate administration is governed by labeling and professional oversight, and most peptides carry no FDA approval for the uses they are marketed for.
Most peptides are administered by subcutaneous or intramuscular injection and dosed in milligrams, micrograms, or international units, with accurate administration tied to product labeling and professional oversight rather than self-direction.
The human gut is built to take peptides apart, which is exactly the problem for anyone hoping a peptide works as a pill. Pepsin and stomach acid begin cleaving peptide bonds, pancreatic enzymes such as trypsin and chymotrypsin finish the job in the small intestine, and the intestinal lining is poorly suited to absorbing the large, water-soluble molecules most peptides represent. Injection sidesteps both barriers by placing the intact molecule directly into tissue, which is why the oral route remains the rare exception rather than the rule.
A peptide taken by mouth is largely degraded by pepsin, stomach acid, and pancreatic enzymes before it can act, which is why injection is the default route and orally viable peptides are a deliberately engineered exception.
There is no single peptide route; the published literature describes a handful, each matched to a molecule's size, stability, and target tissue. The choice is not interchangeable, because what works for a small hormone analog delivered through nasal tissue would fail for a large molecule that needs to be placed under the skin or into a vein. Practical factors weigh in too, including whether a patient can manage self-administration at all.
Subcutaneous injection is the most widely used peptide route because it allows slow, steady absorption and self-administration, while intramuscular, intravenous, nasal, topical, and oral routes are selected based on the peptide's size, stability, target tissue, and required speed of onset.
A peptide dose is not a single fixed number but a calculation that folds in the molecule's potency, the intended effect, and characteristics of the recipient. For approved products, the labeled range comes from clinical trials that escalate amounts to find the level producing the desired effect with acceptable tolerability. The same molecule can be dosed very differently depending on purpose, because the amount needed for one physiological effect may not match the amount needed for another.
A peptide dose is set by combining the molecule's potency, the intended effect, and recipient characteristics such as body weight, and is expressed in milligrams, micrograms, or international units, with approved ranges established through dose-escalation clinical trials.
The single biggest driver of dosing frequency is half-life, the time the body takes to clear half the circulating amount. Native peptides are often gone within minutes to hours because blood and tissue enzymes degrade them fast, which would force inconveniently frequent dosing if nothing slowed that clearance. The practical payoff of engineering a longer-acting version is the difference between several injections a day and a single weekly dose.
A peptide's half-life is the single biggest driver of dosing frequency, with native peptides often cleared in minutes to hours while engineered long-acting versions using fatty acid chains, polymers, or carrier proteins can stretch the schedule to once weekly or longer.
Bioavailability, the proportion of a dose that reaches the bloodstream in active form, sits at the center of nearly every delivery decision. An injected peptide can approach full bioavailability because it skips the destructive passage through the gut, while an oral peptide commonly delivers only a low single-digit percentage of the dose. That stark gap is the reason injection remains the default and oral forms are rare and difficult to develop.
| Criteria | Injected route | Oral route |
|---|---|---|
| Fraction reaching blood | Approaches full delivery | Often low single-digit percentage |
| Reference standard | Intravenous represents complete delivery | Compared against IV reference |
| Dose consequence | Standard administered amount | Amount must be increased substantially |
| Development difficulty | Established default | Rare, requires absorption enhancers |
An injected peptide can approach full bioavailability while an oral peptide commonly delivers only a low single-digit percentage of the dose, which is why injection remains the default and why poor absorption forces the administered amount substantially higher.
Licensed prescribers and pharmacists are the controls that keep peptide dosing safe and appropriate, which is exactly why approved peptide medicines are dispensed by prescription rather than sold freely. A clinician sets the starting dose against the labeling and the individual patient, then monitors response and titrates over time, while the pharmacist acts as an independent check on strength, route, and interactions. This oversight is precisely what is missing in unregulated channels, where purity, accurate labeling, sterility, and correct dosing cannot be assured.
Approved peptide medicines are dispensed by prescription so that a licensed clinician sets and titrates the dose while a pharmacist independently verifies strength, route, and interactions, an oversight structure absent from unregulated supply channels.
Many peptides ship as a lyophilized, freeze-dried powder because peptides are fragile in solution and a dry form dramatically extends shelf life. Storage is strict: unopened powder is usually refrigerated and protected from light, and freezing or excess heat can compromise it. Once reconstituted, the usable window shrinks to weeks under refrigeration, and a long list of common handling errors quietly reduces the delivered dose below what the label implies.
Many peptides are supplied as a freeze-dried powder that must be reconstituted with a sterile diluent and kept refrigerated, and once reconstituted the usable window is often only weeks before potency declines from handling errors such as heat, light, freeze-thaw cycles, and contamination.
The risks documented around peptide administration cluster around measurement, sterility, and product quality, and the most common one is also the most preventable. Doses are often small, so a misread of micrograms versus milligrams, or a botched calculation of how much reconstituted solution equals the intended amount, can deliver a wildly wrong dose. The record is blunt about gray-market supply: mislabeled, underdosed, or impure products mean the actual identity and amount of what is administered may not match the label at all, which undermines any attempt at accurate dosing.
The most common peptide dosing errors are measurement and unit-conversion mistakes between micrograms and milligrams, compounded by non-sterile reconstitution, reused needles, and mislabeled or impure products from unregulated channels where the actual dose and identity cannot be assured.
Educational use only. This article describes what the published scientific and clinical literature reports about Peptides. It is not medical advice, and it does not recommend, prescribe, or tell anyone to use anything described here. The regulatory status shown at the top of this page reflects what the record showed on the date given there and can change. mdpep.com does not sell any substance described here, does not endorse human use of it, and does not direct anyone to obtain it.
This is not guidance for your situation. Nothing here accounts for your medical history, your current medications, or anything else specific to you, and none of it should be used to make a decision about your own health.
Affiliate disclosure. Some links on this site are affiliate links, and mdpep.com may earn a commission when they are used. That never affects what is written here, it is not an endorsement of any vendor, and it is not a statement that anything described on this page is available to buy.
Every claim here ties to a named primary source and a date, written as plain documentation with nothing for sale. That is how MD PEP covers the whole peptide market.
